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Abstract 
 
Objective: Dominant models of illness uncertainty define uncertainty as ‘an inability to 
determine the meaning of illness-related events’. Recent research has shown patient 
uncertainty to be multidimensional encompassing personal issues indirectly affected by 
illness. The nature of carer uncertainty has yet to be fully explored. The present study aimed 
to investigate the nature of illness uncertainty in the carers of patients with Parkinson’s 
disease (PD). 
Design: Eighteen carers of a spouse with PD participated in semi-structured interviews. 
Transcripts were thematically analysed, statements were coded as uncertain if they reflected 
‘a lack of certainty, or a state of limited knowledge, understanding or worry regarding an 
existing or future outcome’.  
Results: The domains of uncertainty expressed by carers closely fitted the five domain 
framework of patient uncertainty: symptoms and prognosis, medical management, self-
management, social functioning and impact. An additional ‘carer-role’ domain was 
identified.  
Conclusions: Carer uncertainty about PD went beyond issues directly related to the illness. 
The findings have implications for research into uncertainty suggesting that widely used 
measures may not be accurately capturing the nature of carer uncertainty about chronic 
illness. The breadth of uncertainty reported has implications for the provision of appropriate 
support to improve caregiver well-being. 
 
Key words: Uncertainty, Parkinson’s, Carers, well-being, adjustment, beliefs  
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Introduction 
A diagnosis of chronic illness causes significant disruption to family life particularly in 
unpredictable and incurable conditions. Evidence suggests that patients with chronic illness 
face significant uncertainty which negatively impacts on their well-being and quality of life 
(QoL) (e.g. Eastwood, Doering, Roper, & Hays, 2008; McCormick, Naimark, & Tate, 2006; 
McNulty, Livneh, & Wilson, 2004; Van Pelt, Mullins, Carpentier, & Wolfe-Christensen, 
2006). Uncertainty is considered to be an inherent aspect of life associated with the ability to 
cope and overcome challenges (Kahneman & Tversky, 1982; Kahneman & Tversky, 1982; 
Lazarus & Folkman, 1984; Weary & Edwards, 1994). Within the spectrum of chronic illness, 
uncertainty has been described as a cognitive stressor that challenges patient adjustment 
(Johnson, Zautra, & Davis, 2006).   
The dominant theories of illness uncertainty, the Uncertainty in Illness Theory (UIT) (Mishel, 
1981, 1988) and the Revised-UIT (RUIT) (Mishel, 1990) define uncertainty as a ‘cognitive 
state created when the person cannot adequately structure or categorise an event due to a lack 
of sufficient cues and thereby cannot determine the meaning of illness related events’ 
(Mishel, 1988, 1990).  The UIT was developed in hospitalised patients with acute illness but 
reconceptualised to explain the experience of living with continuous uncertainty in chronic or 
recurrent illness.  Mishel (1981) proposes four key factors that characterise illness 
uncertainty: i) Ambiguity about the state of the illness, ii) Complexity regarding treatment 
and healthcare systems, iii) Lack of information about diagnosis or seriousness, iv) 
Unpredictability about the course and prognosis. The RUIT explains how uncertainty 
develops and can lead to adaptive outcomes, where uncertainty is viewed as an opportunity or 
becomes integrated into the patient’s life, or maladaptive outcomes where uncertainty is 
viewed as a danger.  
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High levels of uncertainty when perceived as a threat lead to poor coping and adjustment 
(Mishel, 1990). Consequently there is a need to identify factors which make some individuals 
more vulnerable to perceiving uncertainty as a threat rather than an opportunity. This will 
inform the development of interventions to both reduce uncertainty and enable patients to 
cope with persistent uncertainty. Interventions including cognitive reframing, information 
giving, and doctor-patient communication have been trialled in breast and prostate cancer 
with positive effects (Braden, Mishel, & Longman, 1998; Mishel, 1997; Mishel, 2014; 
Mishel et al., 2002). 
However the validity and comprehensiveness of Mishel’s (Mishel, 1988, 1990) definition of 
uncertainty as ‘an inability to determine the meaning of illness related events’ across all 
illnesses and patient groups has been called into question in several qualitative studies 
(Brashers et al., 2003; Cleanthous, Newman, Shipley, Isenberg, & Cano, 2013; Kasper, 
Geiger, Freiberger, & Schmidt, 2008). Research shows that in patients uncertainty extends 
beyond illness related events (e.g. progression) to aspects of life which are indirectly 
impacted by illness (e.g. social functioning) and is condition specific (Cleanthous et al., 
2013). In their exploration of uncertainty in systemic lupus erythematosus (SLE) and 
rheumatoid arthritis (RA) Cleanthous et al. (2013) found five overarching domains of illness 
uncertainty: symptoms and progression, medical management, self-management, impact and 
social functioning. However within these domains illness uncertainty was found to vary 
between the two conditions. Consequently the exploration of uncertainty within the UIT 
models is unlikely to lead to a comprehensive understanding of all aspects of uncertainty 
experienced by patients. 
The UIT and RUIT propose that uncertainty of illness is not just experienced by patients but 
also by those who care for them. Despite this there has been limited research to date 
examining uncertainty in carers. Research that has been undertaken suggests that illness 
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uncertainty is central to carers’ experience of chronic illness and has been associated with 
carer depression, anxiety and life satisfaction (Maikranz, Steele, Dreyer, Stratman, & 
Bovaird, 2007; Unson, Flynn, Glendon, Haymes, & Sancho, 2015; Waldron-Perrine, Rapport, 
Ryan, & Harper, 2009). Much of this research has employed the UIT and RUIT which, as 
with patients, may not be adequately examining all aspects of illness uncertainty in carers. 
Family caregivers provide the majority of care for patients with chronic conditions (Beesley, 
2006). In 2015 it was estimated that there were 6.8 million family carers in the UK 
(approximately 12% of the population), an increase from 5.8 million in 2001 (Buckner & 
Yeandle, 2015). The economic value of informal caregiving is estimated to be as high as 
£132 billion per year in the UK (Buckner & Yeandle, 2015). Caring has significant 
implications for the caregiver. Carers have poorer physical and psychological well-being than 
their non-caring peers and show increased risk of mortality (Schulz, 1999). In view of the 
central role played by family caregivers it is important that efforts are made to maximise 
carer well-being through the identification and amelioration of factors associated with poor 
well-being and QoL. There is a clear need to explore carer uncertainty of illness to enhance 
our understanding of carer adjustment to chronic illness and consequently provide new 
avenues for therapeutic intervention to improve carer QoL. 
Parkinson’s disease (PD) is a chronic, degenerative neurological condition affecting approxi-
mately 127,000 people in the UK (Parkinson's UK, 2015). The disease is characterised by 
motor symptoms including tremor, slowness of movement and rigidity. PD is a condition 
with high uncertainty. The cause of PD is not well understood and there is currently no 
known cure. Prognosis is highly variable with some patients experiencing minimal symptoms 
for several years and others becoming wheelchair bound within a few years of diagnosis. 
Treatment regimens differ substantially between patients and require frequent adjustment as a 
particular drug and dose becomes less effective or side-effects become unmanageable 
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(Mueller, 2012). Research has demonstrated that patients experience uncertainty over the 
effects of PD day to day describing frequent ‘good days’ and ‘bad days’. This uncertainty 
limits the patient’s ability to plan the simplest activities (Hurt, Weinman, Lee, & Brown, 
2012). Uncertainty about the future, particularly with reference to finances, living situation 
and independence were evident in qualitative research (Wright, Hurt, Gorniak, & Brown, 
2015). Explorations of the experience of caring for a person with Parkinson’s have 
highlighted the central role of uncertainty, particularly around patient well-being, disease 
progression and future caregiving (Martin, 2015; Williamson, Simpson, & Murray, 2008).  
This study aimed specifically to test the applicability of Cleanthous et al.’s (2013) five 
domain model of patient uncertainty of illness in a sample of caregivers. Due to its disabling 
nature almost all patients with PD have a carer, most commonly their spouse (Schrag, Hovris, 
Morley, Quinn, & Jahanshahi, 2006). Given the highly uncertain nature of PD and the 
significant role played by carers, PD is an appropriate condition within which to explore carer 
uncertainty of illness.  
Methods 
Participants 
Participants were recruited from the Parkinson’s UK Research Support Network, a network 
of over 500 people with Parkinson’s and their carers from across the UK. Inclusion criteria 
were a) main carer for partner or spouse with a diagnosis of idiopathic PD, b) able to 
communicate fluently in English, and c) partner or spouse provided informed consent for the 
carer to discuss their condition. Ethical approval for the study was granted by City University 
London School of Health Research Ethics Committee (ref: Staff/12-13/28).  
Spouse carers were purposively sampled as they represent the most common form of 
informal caregiver in Parkinson’s. 18 carers were recruited, sample sizes of at least 12 have 
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been found to be adequate in homogenous populations with narrow research objectives 
(Guest, Bunce, & Johnson, 2006) and in theory driven research (Francis et al., 2010). 
Procedure 
The study was advertised via an email sent to all Research Support Network members across 
England. Interested participants were invited to email the study coordinator for further 
information. Both the carer and person with Parkinson’s were provided with information 
sheets and had the opportunity to discuss the study. Both the carer and person with 
Parkinson’s were asked to provide informed consent.  
Data collection 
In-depth semi-structured qualitative interviews were performed using a topic list and 
interview schedule derived from a review of relevant literature to identify topics of interest 
(see supplemental material). All interviews were conducted over the telephone, data was 
recorded and transcribed verbatim. Interviews were conducted by an experienced research 
assistant (MB) who was not familiar with the illness uncertainty literature to prevent bias. 
Use of the term uncertainty was avoided during the interviews. The use of telephone 
interviews has become more common in qualitative research (Irvine, Drew, & Sainsbury, 
2013) with the advantages of allowing greater anonymity when discussing sensitive topics, 
cost and time effectiveness and enabling access to harder to reach groups (Sturges & 
Hanrahan, 2004). Telephone interviews have been found to result in similar quality data as 
face-to-face interviews (Sturges & Hanrahan, 2004), The interviews were conducted between 
October 2013 and January 2014 and lasted from 48 minutes to 2 hours and 30 minutes.  
Analytical approach 
The primary focus of the study was to identify themes of uncertainty described by carers 
when discussing their partner’s Parkinson’s and compare and contrast these to Cleanthous et 
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al.’s five domain model developed in patients. Transcripts were analysed thematically using a 
detailed line by line coding to examine uncertainty domains following Braun and Clarke’s 
(2006) six-step approach. Quotations were coded as ‘uncertain’ on the basis of ‘a lack of 
certainty, or any state of limited knowledge, understanding or worry regarding an existing or 
future outcome’ (Cleanthous et al., 2013) using QSR Nvivo 10. Each quotation was then 
compared to the conceptual domains of uncertainty found by Cleanthous et al. (2013). New 
codes and domains were created where quotations expressing uncertainty did not adequately 
fit within the existing framework. 
Reliability and validity 
Instances of uncertainty were coded by the research assistant (MB) and the main author (CH) 
and high agreement was found across the interviews. The uncertainty domains described are 
supported by direct quotations to allow readers to evaluate the author’s analysis.  
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Results 
The sample characteristics are shown in table 1. All participants were from a white British 
background. 
 
INSERT TABLE 1 HERE 
 
 
Uncertainty Domains 
The full list of domains and subdomains of uncertainty developed by Cleathous et al. (2013) 
can be found in Table 2 along with emerging domains and subdomains found in the present 
study. Each of the domains from the model are examined in detail for fit within the carer 
sample and extended where appropriate to reflect carer uncertainty. 
Symptoms and prognosis 
Uncertainty regarding symptoms and prognosis were common in carer narratives. Carers 
expressed uncertainty about their spouses’ current health status. Carers had difficulty judging 
how severe symptoms were and whether they had deteriorated as they felt they were masked 
by medication.  
“I mean the symptoms he first presented with, about 18 years ago…he may still have some of 
those symptoms, but the medication has masked some of those.” Participant 15 
Carers frequently made comparisons between their spouse’s health status and other people 
they knew with Parkinson’s viewing them as not as bad as or much worse than others. But the 
variable nature of PD made them uncertain how well their spouse actually was.   
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 “…he goes to our group now and he doesn’t seem much different; he hasn’t deteriorated 
much at all, in my eyes, although he’s much younger than us.  Whereas [my spouse] does 
seem to have deteriorated quite a lot.” Participant 1 
Uncertainty around interpretation of symptoms was a strong theme throughout the interviews. 
A lack of clarity was evident around which symptoms were attributable to PD, medication, 
co-morbid conditions or simply aging.  
“I think he has arthritis in his neck which causes him a lot of trouble at night-time, but I 
don’t think that’s related to his Parkinson's, I think that’s related to old-age and arthritis – 
but I’m not sure.” Participant 4 
Carers particularly expressed uncertainty around symptom interpretation before diagnosis and 
only retrospectively attributed symptoms to Parkinson’s. Limited knowledge of the 
symptoms of PD pre-diagnosis was evident in many participants and contributed to delays in 
help-seeking and diagnosis.  
“The night sweats stick out in my mind and as I say, in hindsight, I think that was probably 
Parkinson's.” Participant 3 
This lack of knowledge of potential symptoms was seen to continue on beyond diagnosis 
with many carers still uncertain whether symptoms could be related to PD. This uncertainty 
centred on non-motor symptoms of PD rather than the more commonly known motor 
symptoms.  
“…she’s [Parkinson’s nurse] pointed out symptoms that we weren’t sure were connected 
with Parkinson's if you like; the things that have been coming up…like um, drooling.” 
Participant 12  
There was a high level of certainty among carers that their spouses’ condition would 
deteriorate; the uncertainty about illness progression was how quickly this progression would 
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occur and what the nature of the deterioration would be. This was a major concern for almost 
all carers. 
“Well I’m sure they will [get worse]; I mean that’s the nature of Parkinson's isn’t it?  But 
nobody can predict what will change or how it will change – or when, so…” Participant 3 
PD was viewed by carers as having a high level of uncertainty day-to-day or sometimes 
within a single day. They often described their spouses as having ‘off days’ where their 
movement was more affected which limited their ability to plan daily activities and keep 
social engagements.  
“Sometimes, for no reason, you can just have a bad day and sometimes he’ll just have a 
really good day and you can’t really work out why and just go with it really – make the most 
of the good days.” Participant 5 
Several carers described attempting to try and identify patterns or factors which made things 
better or worse with limited success.  
“So it might be me being…trying to be over-vigilant and spot patterns that are not there just 
yet – not predictive anyway.” Participant 6 
Within the symptoms and prognosis domain Cleanthous et al. (2013) found that patients 
expressed uncertainty about the potential effect of their condition on their life expectancy. 
However no uncertainty regarding spouses’ life expectancy was expressed by carers.  A sub-
domain of symptoms and prognosis which appeared relevant to carers but did not appear in 
patients was uncertainty about the cause of illness. While many carers understood that PD 
was caused by a lack of dopamine they still expressed distress at not understanding why it 
should occur in their spouse. 
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“you know I mean I know there are different theories going on all over the place, but you 
know, [spouse] never worked in agriculture, he’s never worked with chemicals. So, I don’t 
know. I wish I did.” Participant 13 
Medical Management 
Medical management was a central theme in the carers’ discussions of PD. Much of their 
caring role involved managing medication and medical appointments. Although there was a 
relatively high degree of certainty that treatment was largely helpful, a considerable amount 
of uncertainty still surrounded drug treatment.  Future changes in drug regimens were seen as 
very uncertain with approaches to treatment often being described as trial and error. Most 
carers felt that their spouse would have to change drugs in the future but what that change 
may be, and whether there actually was another drug to change to, was uncertain. There was 
an acknowledgement that Parkinson’s varied greatly between patients and individual 
response to drugs was equally variable. Most carers were certain that the doctors were doing 
all they could to manage the condition but it was inevitable that drugs would need to be 
frequently changed until a good response was achieved. 
“I think it may be the only option to go on trial and error.  You know you can double up the 
tablets and see if it works.” Participant 1 
Some carers expressed hope for the development of a drug which may significantly improve 
symptoms or completely cure PD.   
“And I am hoping, I’m not looking for a cure, but I’m hope – why I’m sort of interested in 
research, hoping that there’ll be something quite shortly that will stop it in its tracks.  So, 
given, and then if that happens, if he can get some improvement with his mobility, then maybe 
we can enjoy again a reasonable quality of life.” Participant 5 
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There was also a lack of certainty around the potential side effects of anti-parkinsonian 
medication. Carers were unclear whether certain symptoms were caused by drugs, were part 
of another disease process, were purely psychological, or were due to PD itself. 
“I think that causes considerable confusion [medication], in Parkinson's people, in certain 
people…. there’s never much said about the confusion side of it, I don’t think. And I think 
those symptoms sometimes can be very worrying, because you don’t know whether it’s the 
start of dementia or it is just the drugs.”  Participant 10 
There was also concern at the number of drugs some patients were taking and the potential 
effects on their health. 
“I’m hoping that we can reduce the [name of tablet], ‘cos I suspect it’s not doing anything at 
all, just damaging his liver.” Participant 12 
Carers showed a high level of knowledge about the drugs their spouse was taking and did not 
express any uncertainty about the purpose of those medications.  
It was widely acknowledged by carers that medical professionals had a high degree of 
uncertainty when it came to managing PD. For some this resulted in negative feelings of 
being ‘fobbed off’ and left to help themselves, while others believed that medical staff were 
doing all they could to try and help patients. 
“…because of the progression of Parkinson's, because it’s so different in everybody, nobody, 
the best neurologist in the world could not look at [spouse] and tell me what’s gonna happen 
to him.  And they would admit that; they can’t.  There’s just no way of knowing.” Participant 
13 
“When we speak to the professionals, the neurologist, whoever, they never really differentiate 
between it could be because of sensitive bladder because of prostate or it could be a sensitive 
bladder because of Parkinson's.  They just listen and acknowledge but they don’t really 
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define.  …we still have checks with the cancer specialist every six months, we ask about the 
tiredness which really came on with a vengeance with the radiotherapy, and they’re not sure 
really whether he’s still tired because of that, or whether it’s the Parkinson's.  To be honest 
with you they all seem to pass the buck to each other.” Participant 4 
Some carers questioned how up-to-date medical staff were on recent advances in treatment 
and how willing they were to be flexible in their approach, incorporating individual patient 
needs. This inevitably led carers to question whether their spouse was receiving the best 
available care. In particular carers noted uncertainty around general knowledge of PD and 
ability to diagnose and manage PD in general practice.  
“I don’t think the GP’s are as educated as they should be.  I think there’s a bit of an area 
there lacking.  Because they, they all say well it’s…and you know I know they can’t be 
specialists in everything but I, I don’t think they are totally aware of…of um, of everything.” 
Participant 10 
When it came to formal support from the hospital carers expressed some uncertainty about 
whether their spouse was receiving all of the support that should be available to them. Carers 
described local variation in availability of support (e.g. Parkinson’s nurse visits) and long 
waits for appointments to see physiotherapists and speech and language therapists. Carers 
reported sourcing support themselves rather than being informed about available support by 
the hospital team or GP.  
“We’re becoming aware that perhaps he’s not had um, everything that he should have; not 
had all the support that he should have had.  That um, I’m now not entirely sure that I know 
what.” Participant 12 
Some carers expressed a lack of certainty around how often their spouse should expect to see 
health professionals (e.g. neurologist, Parkinson’s nurse) and what would prompt a visit. 
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“There doesn’t seem to be any specific time, like we see the specialist every six months, 
there’s no specific time for the Parkinson's Nurse…, I think it must have been about a 
year…” Participant 12 
Interestingly the continuity of care sub-domain seen in patients was not found in the carer 
sample. This is interesting as trust in the doctor, formal support and treatment were common 
themes yet carers did not seem concerned about the ability to continue receiving treatment 
from the same specialist or team.  
Self-Management 
Several carers were uncertain if there was anything their spouse could do to manage their 
own condition. Some had attempted exercise but found that co-morbidities made this difficult 
or were unsure if it was having any beneficial effect. 
“I really don’t know what could be done to improve it.  That we’re not already doing.  I have 
no answer to that one.” Participant 18 
The self-management domain was not found to be a strong theme amongst carers. The sub-
domain personal control over prognosis was not present at all in the participant responses. 
Potentially carers felt that there was little that patients could do to manage their own 
condition and held a strong medical model of the condition and treatment. An alternative 
explanation may be that when discussing uncertainty carers were focused on their own role, 
rather than that of the patient, and consequently the concept may have lacked salience to 
carers. Carers may be aware that their role is likely to extend and therefore though self-
management by the patient maybe desirable, in reality it may appear unrealistic.  
 
Impact 
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Future financial stability was a source of uncertainty for many carers, mainly due to potential 
nursing costs both at home or in residential care.  
“I’m concerned about if he had to go into a nursing home, how that would be financed” 
Participant 5 
Forward planning was perceived as difficult by carers due to the unpredictable nature of PD. 
Many described being unable to plan short term events such as lunch dates, while others 
described uncertainty around longer term planning with retirement plans being constantly 
revised as the condition progressed. 
“You never know how he’s going to feel from one day to the next.  Er, so if people ask you 
out to their place for lunch or something, he’ll/you’ll say well look at this point in time he can 
manage it, but I don’t know how he will be in a week’s time.” Participant 15 
“We’ve got a five…we had a 20-year plan for seeing the world, it’s a five-year plan now and 
we’re sort of changing the order in which we do things to um, do the perhaps more difficult 
things sooner rather than later.” Participant 12 
Again the unpredictability of the condition led to uncertainty about the impact of PD on the 
patient’s mobility and functioning in the future. Most carers felt that PD had been 
increasingly impacting upon their spouse’s functional ability but did express some 
uncertainty around whether they had taken over household chores because they had taken on 
a caring role rather than the patient being unable to perform these activities. 
As may be expected due to the different demographic profile of the current sample (married, 
older adults, higher proportion of males), within the impact domain, reference to uncertainty 
around having and raising children was not made and few references were made to 
uncertainty around sustaining a partner and finding and maintaining a job. 
Social Functioning   
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Finally the social functioning domain appeared less central in carers’ narratives and wasn’t 
well supported by the data. Only one participant expressed uncertainty over disclosure of 
diagnosis to others and only two participants reported uncertainty around the social reaction 
of others to PD. This again may be a consequence of the age of the sample; a large proportion 
were already retired at diagnosis or were nearing retirement which would reduce anxiety 
about revealing a condition. Furthermore, long term conditions are much more common 
amongst older adults and may not be met with the same stigma that they might in a younger 
age group. It is also likely that friends and relatives would have come into contact with other 
people with PD and consequently had some understanding of the condition. The majority of 
uncertainty statements in this domain were about accessing social support but carers did not 
differentiate between support for themselves or the patient. Only two carers explicitly 
referred to social support for the patient. 
 
INSERT TABLE 2 HERE 
Carer Role 
As may be expected, in addition to the five domains of uncertainty found in patients by 
Cleanthous et al. (2013), a sixth ‘carer role domain’ was found in the present sample. While 
the domains discussed above refer to the carer’s uncertainty about the patient and their 
condition, the carer role domain specifically refers to carers’ uncertainty about their own role 
and the impact of the condition on themselves. Participants were uncertain if they would be 
able to access support for themselves as carers, emotionally, financially and practically from 
both formal and informal sources. There was some uncertainty around whether friends and 
family would be willing to provide more help and support if it was needed and indeed 
whether they would be physically able to help out. 
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“There’s people in the block of flats we know who I’m sure if asked would help. Although of 
course many are of a certain age and probably not that able in many ways.” Participant 9 
Many carers were unclear about the services that were currently available to them and 
mentioned finding out about services accidently rather than being informed.  
“I’m not sure what help I can get to carry out that role.  Or even stop carrying out that role. 
But that’s the big thing isn’t it? If somebody needs medical attention, will it be there?” 
Participant 6 
This was closely linked with spouses’ uncertainty about their ability to cope in the longer 
term. This encompassed coping with the physical challenges of an increasingly disabled 
partner and the emotional challenges brought with progression of PD. Many carers expressed 
worry and guilt at the idea of their partner having to move to residential care if they were 
unable to provide adequate care at home.  
“I’m just worried that I won’t be able to manage at some stage. And as I say I wouldn’t like 
her to go into a home; I’d like to look after her for as long as possible.” Participant 1 
Uncertainty about the ability to cope was not simply viewed as a consequence of advancing 
disease but also as a potential consequence of the spouse themselves experiencing long term 
health problems.  
“You are ageing along the same, you’re not getting any younger, and you’re just hoping that 
your health er, will be such that you can continue in that caring role for as, as long as needs 
be.  Because that, you know that, that really plays on your mind, you know, what-if, what-if?  
What if I wasn’t around?  What if something happened to me?  What if I couldn’t do what I’m 
doing? And um, that really is, very concerning.” Participant 14 
Carers talked specifically about the expectations of them as a carer. They expressed 
uncertainty about what the role might entail in the future and if they would be able to fulfil 
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those expectations.  
“Well there’s a certain trepidation ‘cos you don’t really know what the future holds. But you 
know you… that’s, that’s the role isn’t it so…” Participant 3 
Finally carers expressed uncertainty about how the role had impacted upon their lives and 
whether this would change in the future with potential illness progression.  
“Well I’ve had to cut back on what I do anyway, but I’m not sure whether that’s gonna be 
permanent.” Participant 1 
Most carers discussed the progression of PD and increasing disability as a certainty with the 
uncertainty surrounding their ability to adapt to and cope with this change.  
Illness Duration 
The median duration of illness was 10 years. In order to explore potential changes in 
uncertainty with disease progression we divided the sample into two groups based on disease 
duration (up to 10 years (N=8) and over 10 years (N=10)). Carers in the shorter duration 
group reported more uncertainty around their role as a carer and the availability of support for 
them in the future (mentioned by 3 participants in the shorter duration group and 1 participant 
in longer duration group). They also expressed more uncertainty about the ability of the 
patient to self-manage their condition (mentioned by 5 participants) than the longer duration 
group (mentioned by 2 participants). These findings may be a reflection of the greater 
experience of the longer duration group both of the disease and as a carer. 
Discussion 
Consistent with the findings of Cleanthous et al. (2013) illness uncertainty in carers did 
extend beyond events directly related to illness (e.g. illness progression, treatment) to 
personal events indirectly affected by the illness (e.g. social support, financial concerns, 
forward planning). A new carer domain of illness uncertainty was found which involved 
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uncertainty around the requirements of the caring role, ability to cope with the role, support 
received and the impact of the role. The nature of uncertainty experienced by carers was also 
found to change with illness duration.  
Interestingly the uncertainty domains of self-management, social functioning and impact 
were discussed less frequently by carers than the medical management, and symptom and 
prognosis domains. These findings may suggest that carers are not fully considering the 
social implications and impact of illness on the patient because they are considering the 
condition from their own perspective rather than the patient’s. However the dominance of 
medical management is in many ways not surprising as, for example, medication plays a 
central role in the management of Parkinson’s disease and missed doses and changes in 
medication can have profound effects on symptoms (Grosset, Bone, & Grosset, 2005). 
Therefore, it may be expected that medical management would feature heavily in carer 
narratives about PD. It remains unclear whether these domains are actually less important in 
PD or less important for carers regardless of the condition.  PD patient interviews and carer 
interviews in other conditions would help to illuminate whether these differences such as 
self-management were a product of the condition or the carers emphasis on medical 
management.  
 
Within the symptoms and prognosis domain carers did not express any uncertainty regarding 
their partner’s life expectancy. There are a number of potential reasons for this finding, the 
participants in this study had an average age of 65 years and life expectancy issues may have 
been less salient in this older sample compared to younger patients. Alternatively, 
participants may have felt uncomfortable speculating about their partner’s life expectancy. 
Finally, there was a high level of certainty among the sample that PD was progressive and 
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had a general downward trajectory, consequently they may have been certain that PD would 
impact on their partner’s life expectancy. 
Despite the differences in uncertainty identified between the present sample of carers and the 
patient samples used by Cleanthous et al (2013), the Cleanthous model appears useful for 
conceptualising carer uncertainty. The domains of the model were all identified in the carer 
sample with only one new domain, carer role, arising. Differences in the subdomains were 
evident however the Cleanthous model already allows for these to vary with illness type. 
Consequently we believe that the Cleanthous model provides an adequate basis for the 
development of a carer specific model of uncertainty of illness.   
The present research identified a range of areas of illness uncertainty experienced by spouse-
carers. Some of these areas of uncertainty are potentially amenable to change through 
education and communication interventions. Information giving interventions have seen 
success in decreasing uncertainty e.g. (Mishel et al., 2002). Improving access to information 
about the symptoms of PD, particularly non-motor symptoms and potential side effects of 
medication could help carers to more easily differentiate between symptoms of PD, other 
conditions, and side-effects of medication. Improved knowledge may enable patients and 
carers to engage in appropriate self-care and seek appropriate help. Improving knowledge in 
GPs may also enhance support and diagnosis (Abbott, Naismith, & Lewis, 2011).  
 
The identification of a carer role domain of uncertainty highlights the importance of 
supporting informal carers in their role. Providing clearer signposting to formal support for 
both patients and carers could alleviate significant uncertainty. Indeed it has been suggested 
that carers could be better supported by helping them to anticipate the effects of the caring 
role to reduce uncertainty (Unson et al., 2015). The findings further suggest that uncertainty 
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may change over the course of a disease and interventions may need to be tailored to 
individual patients.  
 
Although some elements of uncertainty described by carers can be addressed through 
improved information and communication, some are an inherent aspects of the condition and 
rather than attempting to provide certainty, interventions should seek to help carers to cope 
effectively with illness uncertainty.  Mindfulness interventions or Acceptance and 
Commitment Therapy may be effective methods of increasing tolerance of uncertainty 
(Wright, Afari, & Zautra, 2009). A trial of mindfulness in PD is currently underway and will 
explore the impact of mindful exercises on tolerance of uncertainty and may indicate whether 
this approach would be useful for PD carers (Bogosian et al., in press).   
 
It must be acknowledged that the findings of the present research are limited to the sample 
studied. All participants were spouse-carers and all from a white British background. 
Consequently the uncertainty experienced by non-spouse carers such as children, friends or 
other family members and those from other cultural backgrounds may differ considerably to 
that found in the present study. Furthermore we cannot be certain the findings are applicable 
across all caregivers or to what extent carer illness uncertainty may vary across conditions.  
However the findings do suggest that using Mishel’s (Mishel, 1981, 1988, 1990) narrow 
definition of illness uncertainty fails to capture central elements of carers’ uncertainty. It is 
essential that the nature of uncertainty experienced by carers is fully understood so that 
appropriate support and interventions can be provided to improve well-being. 
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The present study aimed to explore the nature of illness uncertainty in carers of people with 
Parkinson’s. While the data allows us to draw conclusions about the domains affected by 
uncertainty, questions still remain regarding the impact of different aspects of uncertainty on 
carers and carer well-being. It is likely that some forms of uncertainty are more problematic 
than others, require greater coping resources, and have a greater impact upon well-being. 
Understanding how carers experience and manage uncertainty is important for the 
development of interventions aimed at the reduction, or acceptance, of uncertainty and would 
be usefully explored in future research.      
 
The findings have implications for our understanding of the nature of illness uncertainty in 
caregivers. Uncertainty clearly extends beyond factors directly related to the illness and 
encompasses a range of factors associated with carrying out the caring role. Further 
exploration of uncertainty of illness in patients with PD and across a broader range of carers 
would strengthen the findings of this study, inform potential intervention strategies, and 
enable the development of a comprehensive model and measure of illness uncertainty in 
caregivers.  
 
 
Acknowledgements 
This study was funded by the City University London Pump Priming Scheme. The authors 
would like to thank Parkinson’s UK for assisting with recruitment for the study. The authors 
have no conflicts of interest to disclose. 
 
 
24 
 
References 
Abbott, L. M., Naismith, S. L., & Lewis, S. J. (2011). Parkinson's disease in general practice: 
assessing knowledge, confidence and the potential role of education. J Clin Neurosci, 18(8), 
1044-1047. doi: 10.1016/j.jocn.2010.12.041 
Beesley, L. (2006). Informal Care in England  Retrieved 06/09/2012, 2012, from 
www.kingsfund.org.uk/document.rm?id=8283  
Bogosian A., Hurt C., Vasconcelos e Sa D., Hindle J., McCracken L., Cubi-Molla, P. (In press). 
Distant delivery of a mindfulness-based intervention for people with Parkinson’s Disease: a 
distant-delivered randomised pilot trial. BMC Neurology. 
Braden, C. J., Mishel, M. H., & Longman, A. J. (1998). Self-Help Intervention Project. Women 
receiving breast cancer treatment. Cancer Practice, 6(2), 87-98. doi: 10.1046/j.1523-
5394.1998.1998006087.x 
Brashers, D. E., Neidig, J. L., Russell, J. A., Cardillo, L. W., Haas, S. M., Dobbs, L. K., . . . Nemeth, 
S. (2003). The medical, personal, and social causes of uncertainty in HIV illness. Issues Ment 
Health Nurs, 24(5), 497-522.  
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in 
Psychology, 3(2), 77-101. doi: 10.1191/1478088706qp063oa 
Buckner, L., & Yeandle, S. (2015). Valuing Carers 2015: The rising value of carers support. London: 
Carers UK. 
Cleanthous, S., Newman, S. P., Shipley, M., Isenberg, D. A., & Cano, S. J. (2013). What constitutes 
uncertainty in systemic lupus erythematosus and rheumatoid arthritis? Psychol Health, 28(2), 
171-188. doi: 10.1080/08870446.2012.701628 
Eastwood, J. A., Doering, L., Roper, J., & Hays, R. D. (2008). Uncertainty and health-related quality 
of life 1 year after coronary angiography. Am J Crit Care, 17(3), 232-242; quiz 243.  
Francis, J. J., Johnston, M., Robertson, C., Glidewell, L., Entwistle, V., Eccles, M. P., & Grimshaw, J. 
M. (2010). What is an adequate sample size? Operationalising data saturation for theory-
based interview studies. Psychol Health, 25(10), 1229-1245. doi: 
10.1080/08870440903194015 
Grosset, K. A., Bone, I., & Grosset, D. G. (2005). Suboptimal medication adherence in Parkinson's 
disease. Mov Disord, 20(11), 1502-1507. doi: 10.1002/mds.20602 
Guest, G., Bunce, A., & Johnson, L. (2006). How Many Interviews Are Enough?: An Experiment 
with Data Saturation and Variability. Field methods, 18(1), 59-82. doi: 
10.1177/1525822x05279903 
Hurt, C. S., Weinman, J., Lee, R., & Brown, R. G. (2012). The relationship of depression and disease 
stage to patient perceptions of Parkinson's disease. J Health Psychol, 17(7), 1076-1088. doi: 
10.1177/1359105311428537 
Irvine, A., Drew, P., & Sainsbury, R. (2013). ‘Am I not answering your questions properly?’ 
Clarification, adequacy and responsiveness in semi-structured telephone and face-to-face 
interviews. Qualitative Research, 13(1), 87-106. doi: 10.1177/1468794112439086 
Johnson, L. M., Zautra, A. J., & Davis, M. C. (2006). The role of illness uncertainty on coping with 
fibromyalgia symptoms. Health Psychology, 25, 696-703.  
Kahneman, D., & Tversky, A. (1982). The Simulation Heuristic,. In P. S. a. A. T. D. Kahneman (Ed.), 
Judgment Under Uncertainty: Heuristics and Biases. New York: Cambridge University 
Press. 
Kahneman, D., & Tversky, A. (1982). Variants of Uncertainty. Cognition(11), 143-157.  
Kasper, J., Geiger, F., Freiberger, S., & Schmidt, A. (2008). Decision-related uncertainties perceived 
by people with cancer--modelling the subject of shared decision making. Psychooncology, 
17(1), 42-48. doi: 10.1002/pon.1190 
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer. 
Maikranz, J. M., Steele, R. G., Dreyer, M. L., Stratman, A. C., & Bovaird, J. A. (2007). The 
Relationship of Hope and Illness-Related Uncertainty to Emotional Adjustment and 
Adherence Among Pediatric Renal and Liver Transplant Recipients. J Pediatr Psychol, 32(5), 
571-581. doi: 10.1093/jpepsy/jsl046 
25 
 
Martin, S. C. (2015). Psychosocial Challenges Experienced by Partners of People With Parkinson 
Disease. J Neurosci Nurs, 47(4), 211-222. doi: 10.1097/JNN.0000000000000141 
McCormick, K. M., Naimark, B. J., & Tate, R. B. (2006). Uncertainty, symptom distress, anxiety, and 
functional status in patients awaiting coronary artery bypass surgery. Heart & Lung: The 
Journal of Acute and Critical Care, 35(1), 34-45. doi: 10.1016/j.hrtlng.2005.08.002 
McNulty, K., Livneh, H., & Wilson, L. M. (2004). Perceived Uncertainty, Spiritual Well-Being, and 
Psychosocial Adaptation in Individuals With Multiple Sclerosis. Rehabilitation Psychology, 
49(2), 91-99.  
Mishel, M. H. (1981). The measurement of uncertainty in illness. Nurs Res, 30(5), 258-263.  
Mishel, M. H. (1988). Uncertainty in illness. Image J Nurs Sch, 20(4), 225-232.  
Mishel, M. H. (1990). Reconceptualization of the uncertainty in illness theory. Image J Nurs Sch, 
22(4), 256-262.  
Mishel, M. H. (1997). Uncertainty in acute illness. [Review]. Annu Rev Nurs Res, 15, 57-80.  
Mishel, M. H. (2014). Theories of uncertainty in illness. In M. J. Smith & P. Liehr (Eds.), Middle 
range theory for nursing (third ed., pp. 53-86). New York, NY: Springer. 
Mishel, M. H., Belyea, M., Germino, B. B., Stewart, J. L., Bailey, D. E., Robertson, C., & Mohler, J. 
(2002). Helping patients with localized prostate carcinoma manage uncertainty and treatment 
side effects: nurse-delivered psychoeducational intervention over the telephone. Cancer, 
94(6), 1854-1866.  
Mueller, T. (2012). Drug therapy in patients with Parkinson's disease. Translational 
Neurodegeneration, 1(1), 10.  
Parkinson's UK. (2015). UK Parkinson’s Audit, 2016, from 
https://www.parkinsons.org.uk/sites/default/files/patientmanagement_standardsandguidance.p
df 
Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2006). Caregiver-burden in 
parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. 
Parkinsonism & Related Disorders, 12(1), 35-41. doi: 10.1016/j.parkreldis.2005.06.011 
Schulz R, B. S. R. (1999). Caregiving as a risk factor for mortality: The caregiver health effects study. 
JAMA: The Journal of the American Medical Association, 282(23), 2215-2219. doi: 
10.1001/jama.282.23.2215 
Sturges, J. E., & Hanrahan, K. J. (2004). Comparing Telephone and Face-to-Face Qualitative 
Interviewing: a Research Note. Qualitative Research, 4(1), 107-118. doi: 
10.1177/1468794104041110 
Unson, C., Flynn, D., Glendon, M. A., Haymes, E., & Sancho, D. (2015). Dementia and Caregiver 
Stress: An Application of the Reconceptualized Uncertainty in Illness Theory. Issues Ment 
Health Nurs, 36(6), 439-446.  
Van Pelt, J. C., Mullins, L. L., Carpentier, M. Y., & Wolfe-Christensen, C. (2006). Brief report: 
illness uncertainty and dispositional self-focus in adolescents and young adults with 
childhood-onset asthma. J Pediatr Psychol, 31(8), 840-845. doi: 10.1093/jpepsy/jsj095 
Waldron-Perrine, B., Rapport, L. J., Ryan, K. A., & Harper, K. T. (2009). Predictors of life 
satisfaction among caregivers of individuals with multiple sclerosis. The Clinical 
Neuropsychologist, 23(3), 462-478. doi: 10.1080/13854040802279683 
Weary, G., & Edwards, J. A. (1994). Individual Differences in Causal Uncertainty. Journal of 
Personality and Social Psychology, 67, 308-318.  
Williamson, C., Simpson, J., & Murray, C. D. (2008). Caregivers' experiences of caring for a husband 
with Parkinson's disease and psychotic symptoms. Soc Sci Med, 67(4), 583-589. doi: 
10.1016/j.socscimed.2008.04.014 
Wright, A., Hurt, C. S., Gorniak, S., & Brown, R. G. (2015). An exploration of worry content and 
catastrophic thinking in middle-aged and older-aged adults with and without Parkinson's 
disease. Int J Geriatr Psychiatry, 30(4), 376-383. doi: 10.1002/gps.4146 
Wright, L. J., Afari, N., & Zautra, A. (2009). The illness uncertainty concept: A review. Current Pain 
and Headache Reports, 13(2), 133-138. doi: 10.1007/s11916-009-0023-z 
  
26 
 
 
Table 1. Sample characteristics 
Characteristics Carer n = 18 
Gender, n (%)  
Female 10 (66.6) 
Male 8 (44.4) 
Age   
Mean (SD) 65.4 (5.1) 
Range 56-73 
Years Since Spouse’s 
Diagnosis 
 
Mean (SD) 10.3 (6.0) 
Range 2-24 
Years of Education  
Mean (SD) 15.8 (3.4) 
Range 7-20 
Years Married  
Mean (SD) 35.2 (14.6) 
Range 2-50 
Employment status, n (%)  
Employed 1 (5.5) 
Retired 17 (94.5) 
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Table 2. Uncertainty domains and subdomains from Cleanthous et al. (2013) and 
emerging domains and subdomains in PD carers  
Domains Subdomains Explanation 
Carer uncertainty about 
the patient: 
  
Symptoms and 
prognosis 
Illness characteristics, 
course and progression 
Interpretation of health status Judging how well they are 
Symptom interpretation Interpreting and labelling physical 
sensations, distinguishing from 
other conditions, SEs etc 
Life expectancy* Unsure of effect on LE 
Illness progression/future Unsure of future severity 
Predictability of health status Judging and predicting short and 
long term health status 
Cause† Uncertainty around the cause of 
Parkinson’s 
Medical management 
Ability of drs to manage 
the condition and 
formal care received 
Treatment (necessity, effectiveness 
and side effects) 
Uncertainty over treatment regime, 
are medications absolutely 
necessary, unsure of purpose of 
medication 
Trust in doctor Consultants knowledge and ability 
to help their condition, drs 
uncertainty over prognosis and 
around initial diagnosis 
Formal support From the hospital e.g. phone lines 
etc, uncertainty around the 
meaning and importance of 
medical tests 
Continuity of care* Uncertainty about being able to 
see the same doctors in future, to 
get care abroad 
Self-management 
Ability to manage the 
condition oneself 
Personal control over prognosis* How much control they have over 
their prognosis 
Management of condition Is there anything more they could 
do, what they should or should not 
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do, how much to push themselves 
Impact 
Impact of the illness on 
the patient’s life, mostly 
future based  
Occupational/financial Maintaining, finding a job, 
financial stability 
Having and raising children* Physical stamina, fertility 
Finding/sustaining a partner* Burden of chronic illness on a 
relationship, finding a new partner 
with a diagnosis 
Forward planning General life planning, short term 
and long term, attending events etc 
Functionality/mobility Future mobility and day to day 
physical mobility – impact on 
ADLs 
Social functioning 
Impact on social  
aspects of life 
Social support Can close friends and family be 
counted on and how much support 
can be expected 
Social reaction Uncertainty of understanding of 
the condition, invisibility of 
symptoms 
Disclosing diagnosis Employers, social circle, potential 
partners, expectation of negative 
implications 
Carer uncertainty about 
themselves 
  
Carer role† 
Uncertainty around the 
potential requirements 
of the role, ability to 
cope with the role, 
support received and 
impact of the role 
 
Accessing support† Ability to access support (formal 
and informal), support provision in 
the future 
Coping† Ability to cope physically and 
emotionally, particularly with 
future illness progression 
Impact† Impact of the carer’s new role on 
their life and the marriage 
Role requirements/expectations† Being good enough, what is 
expected of them 
†Emerging domain/subdomain *Subdomain not found in PD carers  
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Supplementary Material 
Topic List  
Dimension Items 
Symptoms (past – present – future) cause - diagnosis 
condition-specific 
unpredictability 
progression 
ambiguity 
Treatments (past – present – future) effectiveness 
side-effects 
trial&error 
link with symptoms 
relapse & change  
ambiguity 
concerns 
Clinician Interaction Trust/competency 
Interpretation of behaviour 
continuity of care 
how to approach 
when to visit the doctor 
being taken seriously 
communicating effectively 
provision of care support 
preferred degree of involvement 
satisfaction with care 
Impact (past – present – future) (Patient) Recreational activities 
functionality 
productivity 
social status 
interpersonal relationships 
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employment 
financial 
psych. Impact 
physical limitations 
living arrangements 
life changes 
adjustment 
Impact (past – present – future) (Carer) Recreational activities 
productivity 
social status 
interpersonal relationships 
employment 
financial 
psych. Impact 
marital relationship (role changes) 
living arrangements 
life changes 
adjustment 
Self-management (past – present – future) present & future 
what can & can`t do 
what should and should not do 
exercise 
life-style issues 
Caring role (past-present-future) Present & future 
Ability to cope (Psychological & 
physical) 
Commitment 
Care decisions 
Information source / word of mouth 
acknowledgment of uncertainty in the 
clinical setting  
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quality & style of information received 
deficiency of information 
Social Support Family reactions 
Reliability 
Security 
Actual level of support 
preferred level of support 
acceptability 
Understanding/comprehension of 
condition 
ambiguity, complexity, unpredictability 
and deficiency of information regarding: 
symptoms, current state of illness, 
treatment/treatment efficiency 
  
 
 
Always keep in mind: 
 
 
less             more               
 
                                       uncertainty 
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Interview Schedule 
Use the main questions to initiate conversation, if the person spontaneously mentions the 
issues you don’t need to ask about them directly. Only use the questions to probe areas that 
have not been covered. 
 
Introduction 
I’m interested in your experiences as a carer of someone with Parkinson’s and what you 
understand and think about their Parkinson’s. I’ll be asking you quite broad questions. There 
are no right or wrong answers, I’m just interested in your thoughts.   
 
 **Remember to keep in mind certainty, uncertainty throughout e.g. if someone says back 
problems caused by husband to quit work probe how sure they are that this was related to 
PD** 
 
Symptoms: 
Could you tell me a little about the symptoms that they experience?  
(have they changed over time, do you think they will change in the future?) 
 
Are you clear about which symptoms are related to their Parkinson’s? (ask about change over 
time, how sure are you that they are related to PD?) 
 
What do you think is the cause of the symptoms they experience (Parkinson’s)? (ask about 
change over time) 
 
Are their symptoms predictable? (ask about change over time) 
 
Treatments: 
Could you tell me a bit about the treatment they currently receive for their Parkinson’s? (ask 
about change over time) 
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How effective do you think their treatment is? 
 
Do they experience any side effects? (How sure are you that these are side effects?) 
 
Do you have any concerns about their treatment? 
 
How does the doctor decide what treatment is most suitable? 
 
Have they had to change their treatment? (will they have to?, what might cause a change?) 
 
Clinician Interaction: 
Can you tell me about the care your partner receives for their Parkinson’s? 
 
How satisfied are you with the care? 
 
If your partner needed to see a doctor or nurse to discuss an issue do you know who to 
approach and how to get hold of them? 
 
When you do see the doctor/nurse are you able to ask the questions you want to and get the 
help that you need? 
 
Are you always clear whether or not you need to ask for help with an issue? 
 
Do you feel that the doctors/nurses are always able to give you the right advice? 
 
Do you feel they have enough support? (How much support would you prefer?) 
 
Impact (patient): 
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How has Parkinson’s affected your partner’s life? (has it always had that impact, might it 
change in the future? (how sure are you?)) 
 
Has it affected their work at all (did it in the past?) 
 
[do they get as much done, has it affected their relationships, recreational activities finances, 
social standing, living arrangements (ask about past, present and future)]. 
 
How has Parkinson’s affected them psychologically? 
 
How has Parkinson’s affected them physically? (only asked if not covered previously e.g. 
symptoms) 
 
Have they had to make changes to their lives? 
 
How much do you feel they have adjusted to the impact of Parkinson’s? (will they in future?)  
 
Impact (carer): 
How has their Parkinson’s affected your life? (Has it always impacted on you? Do you think 
it will impact on you in the future?) 
 
Has it affected your work at all? 
 
[do you get as much done, has it affected your relationships, recreational activities, finances, 
social standing, living arrangements (ask about past, present and future)]. 
 
How has Parkinson’s affected you psychologically? 
 
Have you had to make changes to your life? 
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How much do you feel you have adjusted to the impact of Parkinson’s? (will you in future?) 
 
Has Parkinson’s affected your relationship with your partner? 
 
Self-management: 
What kinds of things can your partner do to try and manage their Parkinson’s themselves? 
(What could they do in the past, what might they be able to do in the future?) 
 
Are there certain things that they should avoid doing that will make their symptoms worse? 
 
Are there things that they should do to make their symptoms better? 
 
Are there any changes to their lifestyle that they have made (or could make) which would 
help them to manage their Parkinson’s e.g. diet, exercise etc. 
 
Caring role: 
Can you tell me a little bit about your role as a carer for your partner? (have you always done 
that, do you think that might change in the future?) 
 
How easy do you find it to cope in your role as a carer (physically and emotionally)? 
 
Do you feel you know what is expected of you as a carer or what might be expected of you in 
the future? How do you feel about that role? 
  
How confident do you feel to make decisions about your partner’s care? 
 
Information: 
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Where do you get most of your information about Parkinson’s? 
 
What are your thoughts about the information you have received from the doctor/nurse about 
Parkinson’s? (and the way you received the information?) 
 
Can doctors/nurses always be certain about the information they give you in clinic? 
 
Do you feel you get enough information about Parkinson’s? 
 
Social support: 
 
Do you get much support from others? (would you if needed?) 
 
Would you prefer more support than you get now? (or less?) 
 
Is the support that you get reliable? 
 
How secure do you feel they you would have the social (and/or financial) support you 
needed? 
 
How easy do you find it to accept support? 
 
How did your family react when your partner was diagnosed with Parkinson’s? 
 
Understanding/comprehension of condition: 
Overall, how well do you feel that you understand your partner’s Parkinson’s? 
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(ask in detail about the following if not already covered above) 
 
How well do you feel your understand their symptoms (whether they are definitely due to 
Parkinson’s, when they are likely to occur, how best to manage them)? 
 
How well do you understand their treatment? (how effective it is, how effective it might be in 
the future, what the side effects are) 
 
